Use of bevacizumab as a first-line treatment for metastatic breast cancer
贝伐珠单抗作为转移性乳腺癌的一线治疗
期刊:Current Oncology
影响因子:3.4
doi:10.3747/co.22.2210
Manso, L; Moreno, F; Márquez, R; Castelo, B; Arcediano, A; Arroyo, M; Ballesteros, A I; Calvo, I; Echarri, M J; Enrech, S; Gómez, A; González Del Val, R; López-Miranda, E; Martín-Angulo, M; Martínez-Jañez, N; Olier, C; Zamora, P
